StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)

Close on Nov 17, 2026Market cap $28.91MP/E –Yield –

Aytu BioPharma total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Aytu BioPharma's total debt was $10.96M at Jun 30, 2026. For fiscal 2026 it was $10.96M, down 14.1% from the year before. The highest annual figure on record is $18.19M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2026Jun 30, 2026$10.96M-14.1%
FY2025Jun 30, 2025$12.75M-15.7%
FY2024Jun 30, 2024$15.13M-7.5%
FY2023Jun 30, 2023$16.36M-10.0%
FY2022Jun 30, 2022$18.19M+8.0%
FY2021Jun 30, 2021$16.85M+1615.5%
FY2020Jun 30, 2020$982.08K–
FY2019Jun 30, 2019$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$10.96M-14.1%
Q3 FY2026CQ1 2026Mar 31, 2026$11.41M+0.1%
Q2 FY2026CQ4 2025Dec 31, 2025$11.86M-25.2%
Q1 FY2026CQ3 2025Sep 30, 2025$12.30M-25.7%
Q4 FY2025CQ2 2025Jun 30, 2025$12.75M-15.7%
Q3 FY2025CQ1 2025Mar 31, 2025$11.39M-31.8%
Q2 FY2025CQ4 2024Dec 31, 2024$15.85M-1.2%
Q1 FY2025CQ3 2024Sep 30, 2024$16.56M+2.7%
Q4 FY2024CQ2 2024Jun 30, 2024$15.13M-7.5%
Q3 FY2024CQ1 2024Mar 31, 2024$16.72M-33.4%
Q2 FY2024CQ4 2023Dec 31, 2023$16.04M-27.2%
Q1 FY2024CQ3 2023Sep 30, 2023$16.12M+11.3%
Q4 FY2023CQ2 2023Jun 30, 2023$16.36M-10.0%
Q3 FY2023CQ1 2023Mar 31, 2023$25.09M+75.9%
Q2 FY2023CQ4 2022Dec 31, 2022$22.05M+33.9%
Q1 FY2023CQ3 2022Sep 30, 2022$14.49M-13.1%
Q4 FY2022CQ2 2022Jun 30, 2022$18.19M+8.0%
Q3 FY2022CQ1 2022Mar 31, 2022$14.27M+1433.4%
Q2 FY2022CQ4 2021Dec 31, 2021$16.47M+1577.3%
Q1 FY2022CQ3 2021Sep 30, 2021$16.66M-4.2%
Q4 FY2021CQ2 2021Jun 30, 2021$16.85M+533.0%
Q1 FY2021CQ3 2020Sep 30, 2020$930.42K–
Q4 FY2020CQ2 2020Jun 30, 2020$982.08K–
Q3 FY2020CQ1 2020Mar 31, 2020$17.40M–
Q2 FY2020CQ4 2019Dec 31, 2019$2.66M–
Q4 FY2019CQ2 2019Jun 30, 2019$0–

More Aytu BioPharma figures

See a number that looks wrong?